RE:RE:Simple - NO sales No LoveMcfart, there are things I agree with and those that I disagree with. The progress made on product development is fantastic. No doubt about that. But as investors, while I appreciate the long term, many of us had invested on the expectations about BioCloud and trust in those expectations i.e. commercialization in November. That timeline has been upheld fairly recently and not months ago. I did not invest at 40 cents so my bet is on BioCloud and what it can contribute to Kontrol long term, in addition to all the other business. Without BioCloud, KNR is overvalued. I like the space they are in even without BioCloud, but not right now at $3, $4 and $5. If things have drastically changed from a couple of weeks ago, Paul needs to realign expectations. If it means the stock drops $2 then so be it, because it will do so if he doesn't realign expectations anyways, and will just tarnish his credibility. You don't want folk speculating today on a picture that had been painted before, if that picture is not reasonably comparative today.